ApaIRIS (Apatinib, Irinotecan, and S-1)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ApaIRIS (Apatinib, Irinotecan, and S-1), covering 2019-11-05 to 2019-11-05. Get the full timeline:
Most recent: Clinical Trial Update: Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG Regimen [Phase 2]